Following up babies with unclear cystic fibrosis screening results
Part of Genetic & congenital, Lungs & breathing clinical trials.
This study is for babies whose newborn screening suggested possible cystic fibrosis, but the diagnosis is still uncertain after sweat and genetic tests. By joining, you'll help researchers follow these cases to better understand what they mean for your child's health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby had an abnormal newborn screening test for cystic fibrosis, but the diagnosis is still unclear.
- A sweat test came back intermediate (borderline), not clearly normal or clearly high.
- Genetic testing found two changes in the CFTR gene, with at least one change not known to definitely cause cystic fibrosis.
- Your baby does NOT have two changes known to cause cystic fibrosis (so they don't have a confirmed CF diagnosis).
- Your baby does NOT have only one or no CFTR gene changes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at new, advanced tests to help doctors better diagnose cystic fibrosis in people whose current test results are not clear. Participation involves a rectal biopsy, which helps researchers study how the CFTR protein works in the body.
This study tracks the natural course of cystic fibrosis in young children (under 6) and healthy babies over time. It aims to understand how the disease changes in the era of modern treatments, which could help improve care and guide future therapies.
This study collects cells from people with cystic fibrosis (CF) caused by rare CFTR gene changes. The goal is to build a cell bank for future research, which may help scientists develop better tests and treatments for rare CF types.
This study enrolls newly diagnosed infants with cystic fibrosis to follow them during “precision medicine” care. It may help doctors better understand which treatments and monitoring work best, especially before certain infections develop.
This trial checks if taking sweat samples from a baby's arm or leg is equally good for diagnosing cystic fibrosis (CF), a genetic condition that affects the lungs and digestion. It may help make sweat testing easier for babies and their families.
This study looks for simple signals (markers) that may show whether cystic fibrosis treatments are working. It includes people who take CF “modulator” medicines like ivacaftor, people who don’t, and people whose cystic fibrosis was ruled out after testing.
Hear when a new CFTR-RD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.